Merck KGaA to Sell CDMO Business to Lonza
Merck KGaA signed a definitive agreement to sell its Life Science CDMO business to Lonza.
Related stories
JD.com Gets Conditional EU Approval for CECONOMY Acquisition
M impact | MNA | Nov 03, 2026, 11:22 AM UTC
EU Approves Chinese Bid for Europe's Largest Consumer Electronics Stores
The European Commission approved the planned takeover of Europe's largest consumer electronics stores.
M impact | MNA | Nov 03, 2026, 11:18 AM UTC
Karyopharm to Serve as Stalking Horse Bidder in Merger
A SEC filing says Karyopharm Therapeutics will serve as stalking horse bidder for a merger with a reorganized company.
M impact | MNA | Nov 03, 2026, 11:10 AM UTC
Vantive Agrees to Divest Most Hemodialysis Assets to Rockwell Medical
M impact | MNA | Nov 03, 2026, 11:03 AM UTC
Starlink AI Acquisition Agrees to $250 Million Spider Digital Deal
Starlink AI Acquisition agreed to a business combination with Spider Digital valued at $250 million, with support agreements from Spider Digital shareholders and its sponsor.
M impact | MNA | Nov 03, 2026, 11:03 AM UTC
Vantive Agrees to Divest Majority of Hemodialysis Assets to Rockwell Medical
Vantive says it entered into a definitive agreement to sell a majority of its hemodialysis assets and associated operations to Rockwell Medical.
M impact | MNA | Nov 03, 2026, 11:03 AM UTC